AAAAAA

   
Results: 1-5 |
Results: 5

Authors: Hosohata, Y Varga, EV Stropova, D Li, XP Knapp, RJ Hruby, VJ Rice, KC Nagase, H Roeske, WR Yamamura, HI
Citation: Y. Hosohata et al., Mutation W284L of the human delta opioid receptor reveals agonist specificreceptor conformations for G protein activation, LIFE SCI, 68(19-20), 2001, pp. 2233-2242

Authors: Stamer, WD Golightly, SF Hosohata, Y Ryan, EP Porter, AC Varga, E Noecker, RJ Felder, CC Yamamura, HI
Citation: Wd. Stamer et al., Cannabinoid CB1 receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues, EUR J PHARM, 431(3), 2001, pp. 277-286

Authors: Hosohata, Y Vanderah, TW Burkey, TH Ossipov, MH Kovelowski, CJ Sora, I Uhl, GR Zhang, XY Rice, KC Roeske, WR Hruby, VJ Yamamura, HI Lai, J Porreca, F
Citation: Y. Hosohata et al., delta-opioid receptor agonists produce antinociception and [S-35]GTP gammaS binding in mu receptor knockout mice, EUR J PHARM, 388(3), 2000, pp. 241-248

Authors: Hattori, K Suzuki, J Hosohata, Y Ohnuki, T Nakamura, T Watanabe, K Muramatsu, I Nagatomo, T
Citation: K. Hattori et al., Sustaining effects of bopindolol on inhibitory chronotropic actions in guinea pig atria, PHARMACOL, 59(4), 1999, pp. 183-191

Authors: Quock, RM Burkey, TH Varga, E Hosohata, Y Hosohata, K Cowell, SM Slate, CA Ehlert, FJ Roeske, WR Yamamura, HI
Citation: Rm. Quock et al., The delta-opioid receptor: Molecular pharmacology, signal transduction, and the determination of drug efficacy, PHARM REV, 51(3), 1999, pp. 503-532
Risultati: 1-5 |